Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-24
1996-09-03
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548561, C07D207327, A61K 3140
Patent
active
055524311
ABSTRACT:
This invention relates to compounds having the following formula ##STR1## or a pharmaceutically acceptable salt which are useful in the inhibition of platelet aggregation. This invention also relates to pharmaceutical compositions--of such phenyl amidines derivatives.
REFERENCES:
patent: 4073891 (1978-02-01), Okamoto et al.
patent: 4517686 (1985-05-01), Ruoslahti et al.
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4589881 (1986-05-01), Pierschbacher et al.
patent: 4614517 (1986-09-01), Ruoslahti et al.
patent: 4661111 (1987-04-01), Ruoslahti et al.
patent: 4683291 (1987-07-01), Zimmerman et al.
patent: 4791102 (1988-12-01), Bernat et al.
patent: 4857508 (1989-08-01), Adams et al.
patent: 4879313 (1989-11-01), Tjoeng et al.
patent: 4977168 (1990-12-01), Bernat et al.
Haverstick, et al. "Inhibition of Platelet Adhestion to etc."Blood, 66(4), pp. 946-952, Oct. 1985.
E. Rugoslahti, et al. "New Perspectives in Cell Adhesion: RGD and etc."Science, 23 pp. 491-497, (Oct. 1987).
R. Gould, et al. "Disintegrins: A Family of Integrin Inhibitory etc."Proc. Soc. Exp. Biol. and Med., 195(2), pp. 168-171 (Nov. 1990).
M. Goodman, et al. "On the Concept of Linear Modified etc."Accounts of Chemical Research 12(1), pp. 1-7, (Jan. 1979).
M. Ginsberg, et al. "Inhibiton of Fibronectin Binding to Platelets etc."The Journal of Biological Chemistry, 260 (7), pp. 3931-3936 (Apr. 1985).
M. Kloczewiak, et al. "Platelet Receptor Recognition Site on Human Etc."Biochemistry 23(8), 1767-1774 (Jan. 1984).
Z. Ruggeri, et al. "Inhibition of Platelet Function with Synthetic etc."Proc. Natl. Acad. Sci., USA 83, pp. 5708-5712 (Aug. 1986).
E. Plow, et al. "The Effect of ARG-GLY-ASP-Containing Peptides etc.", Proc. Natl. Acad. Sci., USA 82, pp. 8057-8061 (Dec. 1985).
Abood Norman A.
Garland Robert B.
Miyano Masateru
G. D. Searle & Co.
Gerstl Robert
Serauskas Joy Ann
Williams Roger A.
LandOfFree
Peptide mimetic compounds useful as platelet aggregation inhibit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide mimetic compounds useful as platelet aggregation inhibit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide mimetic compounds useful as platelet aggregation inhibit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1950294